| Serial Number | 79296383 |
| Word Mark | SAGA DIAGNOSTICS |
| Filing Date | Thursday, March 5, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, October 5, 2021 |
| Registration Number | 6504579 |
| Registration Date | Tuesday, October 5, 2021 |
| Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, July 20, 2021 |
| Description of Mark | The mark consists of "SAGA" in black capital letters with the left bar of each letter "A" composed of one indigo and one red rectangle. Below it the word "DIAGNOSTICS" appears in smaller black capital letters. |
| Goods and Services | Biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; chemical preparations for use in DNA analysis for medical purposes; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the prevention of tumours; tumor suppressing agents; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating malignant tumors; nucleic acid sequences for medical and veterinary purposes; medical diagnostic reagents and assays for testing of body fluids; clinical medical reagents; veterinary diagnostic reagents; medical diagnostic reagents; reagents for medical use; chemical reagents for veterinary use; chemical reagents for medical use; reagents for microbiological analysis for veterinary use; reagents for microbiological analysis for medical use; diagnostic reagents for medical use; diagnostic reagents for medicinal use; immunoassay reagents for medical use; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; chemical diagnostic reagents for medical use; reagents for analytical purposes for medical purposes; reagents for blood grouping for medical purposes; reagents for microbiological analysis for medical purposes; reagents for analytical purposes for veterinary purposes; reagents for microbiological analysis for veterinary purposes; reagents for use in diagnostic pregnancy tests; chemical reagents for medical or veterinary purposes; reagents for use in analysis for veterinary purposes; reagents for use in analysis for medical purposes; reagents for use with analyzers for medical purposes; reagents for use with analyzers for veterinary purposes; reagents for use in diagnostic tests for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for in-vitro laboratory use for medical purposes; reagents and media for medical and veterinary diagnostic purposes; reagents for in-vitro laboratory use for veterinary purposes; genetic identity tests comprised of reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids; reagents for use in veterinary genetic testing; genetic identity tests comprised of reagents for medical purposes |
| Indication of Colors claimed | The color(s) black, red, and indigo is/are claimed as a feature of the mark. |
| Goods and Services | Lung cancer screening services; prostate cancer screening services; breast cancer screening services; bowel cancer screening services; cervical cancer screening services; providing cancer screening services; testicular cancer screening services; medical analysis services for the diagnosis of cancer; medical analysis services for cancer diagnosis and prognosis; medical services for the treatment of skin cancer; RNA or DNA analysis for cancer diagnosis and prognosis provided by medical laboratories; genetic testing of animals for diagnostic or treatment purposes; medical testing for diagnostic or treatment purposes; DNA screening for medical purposes; drug, alcohol and DNA screening for medical purposes; RNA or DNA analysis for cancer diagnosis and prognosis; medical and health services relating to DNA, genetics and genetic testing; genetic counseling; genetic testing of animals for diagnostic or treatment purposes; genetic testing for medical purposes; genetic testing of animals for diagnostic or treatment purposes |
| Disclaimer with Predetermined Text | "DIAGNOSTICS" |
| Goods and Services | Scientific research for medical purposes in the area of cancerous diseases; scientific laboratory services, laboratory research services relating to detection of sequence variants in DNA or RNA; laboratory testing services relating to detection of sequence variants in DNA or RNA; analytical medical laboratory services; analytical veterinary laboratory services; scientific laboratory services; medical laboratory services; veterinary laboratory services; medical chemical laboratory services; medical biological laboratory services; medical research laboratory services; medical chemical research laboratory services; medical biological research laboratory services; medical laboratory services for analytical testing; medical services of a chemical laboratory; DNA testing services to determine paternity laboratory services; laboratory research services relating to dermatology; laboratory research services relating to pharmaceuticals; medical services of a chemical and/or biological laboratory; medical laboratory services relating to the production of monoclonal antibodies; DNA screening for scientific research purposes; clinical trials for others; conducting clinical trials for others; conducting clinical trials for pharmaceutical products for others; conducting clinical trials in the field of cardiovascular disease for others; conducting clinical trials in the field of acupuncture therapy for others; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical research in the field of cancer and infectious diseases; biological research, clinical research and medical research; basic and clinical research in the field of respiratory science and medicine; pharmaceutical research services; research on the subject of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; pharmaceutical research and development services; laboratory research services relating to pharmaceuticals; research on the subject of pharmaceuticals; consultancy relating to pharmaceutical research and development; research and development for the pharmaceutical industry; consultancy in the field of pharmaceutical research; research and development in the pharmaceutical and biotechnology fields; scientific research, namely, genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; genetic testing for scientific research purposes; scientific research, namely, genetic engineering services relating to plants; medical research in the field of gene therapy; scientific research relating to genetics of plants; laboratory research in the field of gene expression; genetic testing of laboratory animals for research purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 18, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 18, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, November 18, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | SAGA Diagnostics AB |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Party Name | SAGA Diagnostics AB |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Party Name | SAGA Diagnostics AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Event Date | Event Description |
| Monday, July 24, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, December 15, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, December 15, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, December 15, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Thursday, December 15, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, December 15, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, December 15, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, April 18, 2022 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Thursday, March 24, 2022 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, March 24, 2022 | FINAL DISPOSITION PROCESSED |
| Friday, January 21, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, January 5, 2022 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, October 5, 2021 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, July 20, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 20, 2021 | PUBLISHED FOR OPPOSITION |
| Monday, July 19, 2021 | NOTIFICATION PROCESSED BY IB |
| Wednesday, June 30, 2021 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, June 30, 2021 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, June 30, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, June 14, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, June 14, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, June 14, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, June 14, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, June 14, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, June 1, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, June 1, 2021 | FINAL REFUSAL E-MAILED |
| Tuesday, June 1, 2021 | FINAL REFUSAL WRITTEN |
| Saturday, May 1, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, April 30, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 30, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, January 4, 2021 | REFUSAL PROCESSED BY IB |
| Friday, December 11, 2020 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, December 11, 2020 | REFUSAL PROCESSED BY MPU |
| Thursday, November 26, 2020 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, November 25, 2020 | NON-FINAL ACTION WRITTEN |
| Tuesday, November 24, 2020 | APPLICATION FILING RECEIPT MAILED |
| Thursday, November 19, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Thursday, November 19, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, November 19, 2020 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Thursday, November 19, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, November 19, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, November 19, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, November 18, 2020 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Wednesday, November 18, 2020 | ASSIGNED TO EXAMINER |
| Wednesday, November 18, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, November 13, 2020 | NEW REPRESENTATIVE AT IB RECEIVED |
| Thursday, October 22, 2020 | SN ASSIGNED FOR SECT 66A APPL FROM IB |